Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer (Q39682405)

13 September 2017

title

Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer (English)

1 reference

13 September 2017

author

Mohammed A Aleskandarany

Mohammed A Aleskandarany

1

0 references

Emad A. Rakha

Emad A Rakha

2

0 references

Andrew Green

Andrew R Green

6

0 references

Ian Ellis

Ian O Ellis

5

0 references

author name string

Mohamed A Ahmed

3

1 reference

13 September 2017

Desmond G Powe

4

1 reference

13 September 2017

language of work or name

English

0 references

publication date

9 July 2010

1 reference

Breast Cancer Research and Treatment

13 September 2017

published in

1 reference

13 September 2017

volume

127

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

407-416

1 reference

Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

The activation of Akt/PKB signaling pathway and cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Perturbations of the AKT signaling pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

PI3K/PTEN signaling in angiogenesis and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

PI3K/PTEN signaling in tumorigenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Recent advances in the protein kinase B signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Current perspectives on Akt Akt-ivation and Akt-ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

PI3K pathway alterations in cancer: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

PTEN, more than the AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Current overview of the role of Akt in cancer studies via applied immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

The Akt pathway in human breast cancer: a tissue-array-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Dysregulated PTEN-PKB and negative receptor status in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

p53 ubiquitination: Mdm2 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

The association between Akt activation and resistance to hormone therapy in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1012-Y

10.1007/S10549-010-1012-Y

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference